One of this year's top articles on cost and coverage highlights that the average American can afford a maximum of $97 in out-of-pocket healthcare expenses.
Advertisement
HHS Releases Part Two of Medicare Prescription Drug Payment Plan Part two focuses on the requirement that Part D sponsors must make enrollees aware of upcoming benefits. Read here
More than a Third of Americans Have Skipped a Healthcare Visit Due to Inability to Pay The average American can afford a maximum of a $97 for out-of-pocket healthcare expenses. Read here
Lilly Introduces Zepbound Single-Dose Vial for Cash-Paying Patients The monthly price of the 2.5 mg Zepbound single-dose vial is $399 and the 5 mg dose is $549, which Lilly officials said is in line with the savings program for without insurance. Read here
Nonsteroidal Drug for Duchenne Launches with a $700,000 Price Tag Duvyzat was approved in March 2024 and works to reduce the inflammation and loss of muscle experienced by patients with Duchenne muscular dystrophy. Read here
Loren McCaghy of Accenture Suggests Digital Engagement, Ease of Use as Key Drivers in Healthcare Provider and Payer Turnover In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers. Listen here
Five transcranial magnetic stimulation sessions in one day improved processing speed in adults with schizophrenia, which holds promise for future treatment possibilities, according to researcher Heather Burrell Ward, M.D.
One of teledentistry's most valuable applications is triage — helping a patient understand whether a concern can wait for an appointment, requires prompt attention or warrants emergency medical care.